Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis.

El-Jawhari, J.J. ORCID: 0000-0002-0580-4492, 2020. Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis. Clinical and Experimental Rheumatology. ISSN 0392-856X

Full text not available from this repository.
Item Type: Journal article
Publication Title: Clinical and Experimental Rheumatology
Creators: El-Jawhari, J.J.
Publisher: Pacini Editore SpA
Date: 27 May 2020
ISSN: 0392-856X
Identifiers:
NumberType
1339506Other
Divisions: Schools > School of Science and Technology
Depositing User: Linda Sullivan
Date Added: 30 Jun 2020 08:12
Last Modified: 30 Jun 2020 08:12
URI: http://irep.ntu.ac.uk/id/eprint/40134

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year